Research facility · founded 1892

The Wistar Institute

Philadelphia, United States · wistar.org

Manage this page

Citations, last 5 years: 13.8k
Works, last 5 years: 2 014
h-index: 580
Scientists listed: 246
Grants since 2016: 630

Grants received

2004–2020 · research · R01

Mechanism of myeloid cell defect in cancer

Dmitry I Gabrilovich · The Wistar Institute · funded by National Institutes of Health

$311.4k

2004–2020 · research · R01

Mechanism of myeloid cell defect in cancer

Dmitry I Gabrilovich · The Wistar Institute · funded by National Institutes of Health

$311.4k

2003–2020 · research · R01

Functional Analysis of p53 polymorphic variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$384.8kCancer-related Molecular Pathways

2003–2020 · research · R01

Functional Analysis of p53 polymorphic variants

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

$373.2kCancer-related Molecular Pathways

2002–2023 · research · R01

Regulation of EBV Latency by EBNA1

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$380.9kViral-associated cancers and disorders

2002–2023 · research · R01

Regulation of EBV Latency by EBNA1

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$380.9kViral-associated cancers and disorders

2002–2023 · research · R01

Regulation of EBV Latency by EBNA1

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$373.3kViral-associated cancers and disorders

2002–2023 · research · R01

Regulation of EBV Latency by EBNA1

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$380.9kViral-associated cancers and disorders

2002–2023 · research · R01

Regulation of EBV Latency by EBNA1

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

$369.5kViral-associated cancers and disorders

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$2.7M

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$93.6k

1997–2026 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$2.8M

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$100k

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$104.8k

1997–2026 · program · P30

Immunological approaches to overcoming therapy resistance in human tumors

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$750k

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$2.7M

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$2.7M

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$2.7M

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$249.9k

1997–2024 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$2.7M

1997–2026 · program · P30

Consolidated Basic Cancer Research Program

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

$2.8M

1997–2026 · program · P30

Cancer Center Administration

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Flow Cytometry Shared Resource

Luis J Montaner · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Genomics Shared Resource

Alessandro Gardini · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Proteomics and Metabolomics Shared Resource

Hsin-Yao Tang · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Biomedical Research Support Shared Resource

Luis J Montaner · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Molecular Screening and Protein Expression Shared Resource

Joseph M Salvino · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Bioinformatics Shared Resource

Jozef Madzo · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Imaging Shared Resource

Nan Zhang · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Developmental Funds

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

1997–2024 · program · P30

Research Program: Immunology, Microenvironment and Metastasis

Rugang Zhang · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Cancer Research Career Enhancement and Related Activities

Kristy Shuda Mcguire · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Research Program: Gene Expression and Regulation

Paul M. Lieberman · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Animal Shared Resource

Jessie Villanueva · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Leadership, Planning and Evaluation

Dario C Altieri · The Wistar Institute · funded by National Institutes of Health

1997–2026 · program · P30

Research Program: Molecular and Cellular Oncogenesis

Maureen E. Murphy · The Wistar Institute · funded by National Institutes of Health

1992–2022 · research · R01

c-Myc Targets in the Pathogenesis of Human Cancers

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$225.4kCancer, Hypoxia, and Metabolism

1992–2022 · research · R01

c-Myc Targets in the Pathogenesis of Human Cancers

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$248.6kCancer, Hypoxia, and Metabolism

1992–2022 · research · R01

c-Myc Targets in the Pathogenesis of Human Cancers

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$549.8kCancer, Hypoxia, and Metabolism

1992–2022 · research · R01

c-Myc Targets in the Pathogenesis of Human Cancers

Chi V. Dang · The Wistar Institute · funded by National Institutes of Health

$536.4kCancer, Hypoxia, and Metabolism